Abstract
Contact and support
Need help, have a question, or want to contact the ResearchHub team?
© 2026 ResearchHub. Built for responsible scholarly connection.
Guangyong Zheng, Zhijie Guo, Liangxiao Ma, Anqin Zheng, Weiran Chen, Zhen Shao
Abstract
Authors
Institutions
No ROR-resolved institution is linked to this work yet.
Provenance
crossref
Confidence 100%
pubmed
Confidence 98%
europepmc
Confidence 96%
unpaywall
Confidence 95%
doaj
Confidence 92%
datacite
Confidence 0%
No local reference links have been materialized yet.
No local citing links have been materialized yet.
10.1038/nature18606
10.1038/nature18606
The chromatin accessibility landscape of primary human cancers
10.1126/science.aav1898 · 2018
10.1038/nrg2641
10.1038/nrg2641
10.1038/s41596-022-00692-9
10.1038/s41596-022-00692-9
10.1038/s41467-018-04383-6
10.1038/s41467-018-04383-6
10.1016/j.celrep.2018.12.098
10.1016/j.celrep.2018.12.098
10.1093/nar/gkz1062
10.1093/nar/gkz1062
Integrative analysis of 111 reference human epigenomes
10.1038/nature14248 · 2015
From reads to insight: a hitchhiker's guide to ATAC-seq data analysis
10.1186/s13059-020-1929-3 · 2020
A systematic dissection of the epigenomic heterogeneity of lung adenocarcinoma reveals two different subclasses with distinct prognosis and core regulatory networks
10.1186/s13059-021-02376-1 · 2021
HyperChIP: identification of hypervariable signals across ChIP-seq or ATAC-seq samples
10.1186/s13059-022-02627-9 · 2022
CloudATAC: a cloud-based framework for ATAC-Seq data analysis
10.1093/bib/bbae090 · 2024
10.1093/nar/gkae410
10.1093/nar/gkae410
Unresolved referenced work
2023
10.1101/gr.262675.120
10.1101/gr.262675.120
10.1038/s41421-018-0045-y
10.1038/s41421-018-0045-y
10.1145/2723872.2723882
10.1145/2723872.2723882
10.1186/gb-2009-10-3-r25
10.1186/gb-2009-10-3-r25
10.1038/nmeth.1923
10.1038/nmeth.1923
10.1186/gb-2008-9-9-r137
10.1186/gb-2008-9-9-r137
10.1158/0008-5472.can-18-3663
10.1158/0008-5472.can-18-3663
10.1136/gutjnl-2021-326483
10.1136/gutjnl-2021-326483
10.1038/s41467-021-26600-5
10.1038/s41467-021-26600-5
10.1038/ng.3646
10.1038/ng.3646
Integrative pan cancer analysis reveals epigenomic variation in cancer type and cell specific chromatin domains
10.1038/s41467-021-21707-1 · 2021
Cell-lineage controlled epigenetic regulation in glioblastoma stem cells determines functionally distinct subgroups and predicts patient survival
10.1038/s41467-022-29912-2 · 2022
10.1038/s41467-022-29857-6
10.1038/s41467-022-29857-6
Chromatin accessibility associates with protein-RNA correlation in human cancer
10.1038/s41467-021-25872-1 · 2021
10.1038/nrendo.2014.186
10.1038/nrendo.2014.186
The role of activator protein-1 (AP-1) family members in CD30-positive lymphomas
10.3390/cancers10040093 · 2018
Mechanism of AP-1-mediated gene expression by select organochlorines through the p38 MAPK pathway
10.1093/carcin/bgh009 · 2004
Biologic and clinical perspectives on thyroid cancer
10.1056/nejmc1613118 · 2016
Transcription factor Runx2 is a regulator of epithelial-mesenchymal transition and invasion in thyroid carcinomas
10.1038/labinvest.2012.84 · 2012
10.1038/nature16965
10.1038/nature16965
10.1158/2159-8290.cd-18-0349
10.1158/2159-8290.cd-18-0349
Impact of classical and basal-like molecular subtypes on overall survival in resected pancreatic cancer in the SPACIOUS-2 multicentre study
10.1093/bjs/znac429 · 2023
10.1016/j.celrep.2020.107625
10.1016/j.celrep.2020.107625
HNF1A recruits KDM6A to activate differentiated acinar cell programs that suppress pancreatic cancer
10.15252/embj.2019102808 · 2020
Correction: GATA6 expression distinguishes classical and basal-like subtypes in advanced pancreatic cancer
10.1158/1078-0432.ccr-22-1272 · 2022
Metformin inhibits pancreatic cancer metastasis caused by SMAD4 deficiency and consequent HNF4G upregulation
10.1007/s13238-020-00760-4 · 2021
RUNX2 and the PI3K/AKT axis reciprocal activation as a driving force for tumor progression
10.1186/s12943-015-0404-3 · doi-reference
RUNX2 is overexpressed in melanoma cells and mediates their migration and invasion
10.1016/j.canlet.2014.03.011 · doi-reference
10.1038/s41388-020-1351-z
10.1038/s41388-020-1351-z · doi-reference
10.1002/jcp.24285
10.1002/jcp.24285 · doi-reference
RUNX2 promotes breast cancer bone metastasis by increasing integrin alpha5-mediated colonization
10.1016/j.canlet.2016.06.007 · doi-reference
10.1530/joe-11-0048
10.1530/joe-11-0048 · doi-reference
10.1093/nargab/lqab101
10.1093/nargab/lqab101 · doi-reference
10.1038/nbt.1505
10.1038/nbt.1505 · doi-reference
10.1186/gb-2011-12-8-r83
10.1186/gb-2011-12-8-r83 · doi-reference
ChIPseek, a web-based analysis tool for ChIP data
10.1186/1471-2164-15-539 · doi-reference
10.1016/j.cell.2008.01.025
10.1016/j.cell.2008.01.025 · doi-reference
Pax5 regulates B cell immunity by promoting PI3K signaling via PTEN down-regulation
10.1126/sciimmunol.abg5003 · doi-reference
10.1038/s41467-021-25758-2
10.1038/s41467-021-25758-2 · doi-reference
T cell factor 1: a master regulator of the T cell response in disease
10.1126/sciimmunol.abb9726 · doi-reference
10.1053/j.gastro.2010.04.003
10.1053/j.gastro.2010.04.003 · doi-reference
10.1016/j.cell.2020.10.023
10.1016/j.cell.2020.10.023 · doi-reference
RUNX1 promote invasiveness in pancreatic ductal adenocarcinoma through regulating miR-93
10.18632/oncotarget.20433 · doi-reference
Impact of RUNX2 on drug-resistant human pancreatic cancer cells with p53 mutations
10.1186/s12885-018-4217-9 · doi-reference